Fokas, E., Prevo, R., Reaper, P., Charlton, P., Pollard, J., Mckenna, W., . . . Brunner, T. (2012). The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy.
Chicago Style (17th ed.) CitationFokas, E., R. Prevo, P. Reaper, P. Charlton, J. Pollard, W. Mckenna, R. Muschel, and T. Brunner. The Novel ATR Inhibitor VE-821 Selectively Sensitizes Pancreatic Cancer Cells to Radiation and Chemotherapy. 2012.
MLA引文Fokas, E., et al. The Novel ATR Inhibitor VE-821 Selectively Sensitizes Pancreatic Cancer Cells to Radiation and Chemotherapy. 2012.
警告:這些引文格式不一定是100%准確.